NDC 16729-367-45 - OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 16729-367
- Requested NDC
- 16729-367-45
- Package NDCs from labels
- 16729-367-10, 16729-367-15, 16729-367-16, 16729-367-17, 16729-367-45, 16729-367-46
- Manufacturer
- Accord Healthcare Inc. | Intas Pharmaceuticals Limited
- Effective date
- 2025-10-29
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LACTOSE MONOHYDRATE - Accord Healthcare Inc. | Intas Pharmaceuticals Limited | Accord Healthcare Inc. | Intas Pharmaceuticals Limited | 2025-10-29 | HUMAN PRESCRIPTION DRUG LABEL |
| OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE - A-S Medication Solutions | A-S Medication Solutions | 2024-11-13 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 16729-367-10 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 30 in 1 BOTTLE | TABLET, FILM COATED | 30 | 7 | |
| 16729-367-15 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 90 in 1 BOTTLE | TABLET, FILM COATED | 90 | 7 | |
| 16729-367-16 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 500 in 1 BOTTLE | TABLET, FILM COATED | 500 | 7 | |
| 16729-367-17 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 1000 in 1 BOTTLE | TABLET, FILM COATED | 1000 | 7 | |
| 16729-367-45 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 10 in 1 BLISTER PACK | TABLET, FILM COATED | 10 | 7 | |
| 16729-367-46 | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | 100 in 1 CARTON | TABLET, FILM COATED | 100 | 7 |
DailyMed Dashboard NDC Coverage#
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 16729-367-10 | EA - Each | 16729-367 | aea7451f-249f-4002-a7df-f367e3bb0513 | 1 | 2020-09-14 |
| 16729-367-15 | EA - Each | 16729-367 | 0eff996a-5135-4a4b-a09e-70ccc66334d4 | 1 | 2020-09-14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Tinted Mineral Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | ESTHETICS BY RIKI LLC | 37f2c5ed-c2f5-e569-e063-6294a90a15b1 | 2025-06-19 | 15FIX9V2JP | |
| Aloe UP SPF 30 Mineral | ZINC OXIDE, TITANIUM DIOXIDE | Aloe Care International, LLC | 35967b33-bdfb-ee3c-e063-6294a90a75f6 | 2025-06-18 | Warnings | 15FIX9V2JP |
| Aloe Up SPF 50 Mineral | ZINC OXIDE, TITANIUM DIOXIDE | Aloe Care International, LLC | 35b9dcfa-05f3-3d7b-e063-6394a90a18f1 | 2025-06-18 | Warnings | 15FIX9V2JP |
| Aloe Up SPF 50 Kids Mineral | ZINC OXIDE, TITANIUM DIOXIDE | Aloe Care International, LLC | 35cd16b0-bd81-8f68-e063-6294a90a3d8c | 2025-06-18 | Warnings | 15FIX9V2JP |
| hydrochlorothiazide | HYDROCHLOROTHIAZIDE | American Health Packaging | 13ed002f-c5bb-401c-891a-70b70cbd8fb6 | 2025-06-18 | Warnings, Adverse reactions | 0J48LPH2TH |
| Skin by Scottie Beach Mode Mineral Sunscreen Roll-On SPF 30 | TITANIUM DIOXIDE, ZINC OXIDE | SKIN CARE BY SCOTTIE LLC | a9afa58c-f438-48c6-bd30-eda41334df74 | 2025-06-16 | Warnings | 15FIX9V2JP |
| Dermaka Sunscreen SPF 42, Tinted | TITANIUM DIOXIDE, ZINC OXIDE | DERMAKA SKIN PRODUCTS | 9a967cd1-9eec-4255-b14b-ac2e33e4dbf0 | 2025-06-16 | Warnings | 15FIX9V2JP |
| SENSITIVE POCKET SUN | SENSITIVE POCKET SUN | Shantou Oushiya Biotechnology Co., Ltd | 36ac412f-e31f-6906-e063-6394a90a4a3d | 2025-06-14 | Warnings | 7SEV7J4R1U |
| Benazepril Hydrochloride and Hydrochlorothiazide | BENAZEPRIL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | Sandoz Inc | c9bdfbb4-87b6-4de4-bc1d-5025d3ef591f | 2025-06-14 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Hydrochlorothiazide | HYDROCHLOROTHIAZIDE | Unichem Pharmaceuticals (USA), Inc. | 33f3b980-b339-4dbf-99bd-05588c2a298c | 2025-06-13 | Warnings, Adverse reactions | 0J48LPH2TH |
| Losartan potassium and Hydrochlorothiazide | LOSARTAN POTASSIUM AND HYDROCHLOROTHIAZIDE | Bryant Ranch Prepack | 352061ee-942d-6cba-e063-6294a90a9eea | 2025-06-13 | Boxed warning, Warnings, Adverse reactions | 0J48LPH2TH |
| Instantly Dry | TITANIUM DIOXIDE, ZINC OXIDE | CLEAN BEAUTY BY ANAK LLC | 37624bf6-4949-1b10-e063-6294a90ac488 | 2025-06-12 | 15FIX9V2JP | |
| Reflecting Mineral Sunscreen | ZINC OXIDE, TITANIUM DIOXIDE | Helande, LLC | 3750f04b-7f9f-8793-e063-6294a90a9143 | 2025-06-11 | Warnings | 15FIX9V2JP |
| OLMESARTAN MEDOXOMIL and HYDROCHLOROTHIAZIDE | OLMESARTAN MEDOXOMIL AND HYDROCHLOROTHIAZIDE | A-S Medication Solutions | f7415f1d-98c7-454f-bb1a-f59e95652c88 | 2025-06-10 | Boxed warning, Warnings, Adverse reactions | 403854 0J48LPH2TH 6M97XTV3HD |
| SHISEIDO ULTIMATE SUN PROTECTION S | TITANIUM DIOXIDE AND ZINC OXIDE | Shiseido Americas Corporation | b2fae1ba-67fe-48ef-b31f-62db34349961 | 2025-06-09 | Warnings | 15FIX9V2JP |
| Aquavit | AQUAVIT | Uriel Pharmacy Inc. | c1c0887a-c388-c737-e053-2a95a90a076c | 2025-06-06 | Warnings | 1K09F3G675 |
| Rodan and Fields Reverse Brightening Defense Broad Spectrum SPF 50 Mineral Sunscreen | TITANIUM DIOXIDE, ZINC OXIDE | Rodan & Fields Beauty, LLC | afa2d42e-b54d-4843-b313-0c44fe5c5d52 | 2025-06-06 | Warnings | 15FIX9V2JP |
| Body Glove Sunscreen SPF 30 | ZINC OXIDE, TITANIUM DIOXIDE | SCUBASCREEN LLC | 1d7a960c-4387-44dc-8d4e-881e21a8ae2e | 2025-06-05 | Warnings | 15FIX9V2JP |
| Non Tinted Mineral Sunscreen Stick | TITANIUM DIOXIDE, ZINC OXIDE | BABYFACE LLC | 36d7c8b3-554f-78d9-e063-6394a90a80f3 | 2025-06-05 | 15FIX9V2JP | |
| Tinted Mineral Sunscreen Stick | TITANIUM DIOXIDE, ZINC OXIDE | BABYFACE LLC | 36d80422-943f-3aba-e063-6294a90afb59 | 2025-06-05 | 15FIX9V2JP |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.